Sex and body mass index but not CXCL12 801G/A polymorphism determine the efficacy of hematopoietic cell mobilization: A study in healthy volunteer donors

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 10, 2013, Pages 1517-1521

  Lenk, Juliane ^a   Bornhauser, Martin ^a,b   Kramer, Michael ^a   Hölig, Kristina ^a   Poppe Thiede, Kirsten ^c   Schmidt, Helmuth ^c   Wiesneth, Markus ^d   Schaefer Eckart, Kerstin ^e   Schlenke, Peter ^f   Punzel, Michael ^c   Martin, Sonja ^g   Kroschinsky, Frank ^a   Schmidt, Alexander H ^h   Ehninger, Gerhard ^a   Thiede, Christian ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^c Cellex Patient Treatment GmbH   (Germany)

^d German Red Cross Blood Transfusion Service Baden Württemberg Hessen and University Hospital Ulm   (Germany)

^e KLINIKUM NÜRNBERG   (Germany)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^g ROBERT BOSCH HOSPITAL   (Germany)

^h DKMS German Bone Marrow Donor Center   (Germany)

Author keywords

CXCL12; G CSF; Healthy volunteer donors; Hematopoietic cell mobilization; Hematopoietic stem and progenitor cells

Indexed keywords

CD34 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR12; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ADULT; AGE; ALLELE; APHERESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BODY MASS; CONCENTRATION (PARAMETERS); DNA POLYMORPHISM; DONOR; FEMALE; GENOTYPE; HEMATOPOIETIC CELL; HUMAN; LEUKAPHERESIS; LYMPHOCYTE COUNT; MALE; NORMAL HUMAN; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX; SMOKING; STEM CELL MOBILIZATION;

CD34+ MOBILIZATION; CXCL12; G-CSF; HEALTHY VOLUNTEER DONORS; HEMATOPOIETIC CELL MOBILIZATION; HEMATOPOIETIC STEM AND PROGENITOR CELLS;

ADOLESCENT; ADULT; BODY MASS INDEX; CHEMOKINE CXCL12; FEMALE; HEALTHY VOLUNTEERS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX FACTORS; TISSUE DONORS; YOUNG ADULT;

EID: 84884186762     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.07.018     Document Type: Article

References (18)

1. Bensinger W.I., Martin P.J., Storer B., et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. NEngl J Med 2001, 344:175-181.
2. Hölig K., Kramer M., Kroschinsky F., et al. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood 2009, 114:3757-3763.
3. Ben Nasr M., Reguaya Z., Berraies L., et al. Association of stromal cell-derived factor-1-3'A polymorphism to higher mobilization of hematopoietic stem cells CD34+ in Tunisian population. Transplant 2011, 43:635-638.
4. Winkler I.G., Levesque J.P. Mechanisms of hematopoietic stem cell mobilization: When innate immunity assails the cells that make blood and bone. Exp Hematol 2006, 34:996-1009.
5. Suzuya H., Watanabe T., Nakagawa R., et al. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sang 2005, 89:229-235.
6. Martino M., Callea I., Condemi A., et al. Predictive factors that affect the mobilization of CD34(+) cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF). JClin Apheres 2006, 21:169-175.
7. Vasu S., Leitman S.F., Tisdale J.F., et al. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood 2008, 112:2092-2100.
8. Okano A., Ashihara E., Shimazaki C., et al. Predictive parameters for granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. JClin Apheres 2008, 23:171-177.
9. Morris C.L., Siegel E., Barlogie B., et al. Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen. Br J Haematol 2003, 120:413-423.
10. To L.B., Levesque J.P., Herbert K.E. How I treat patients who mobilize hematopoietic stem cells poorly. Blood 2011, 118:4530-4540.
11. Aiuti A., Webb I.J., Bleul C., et al. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. JExp Med 1997, 185:111-120.
12. Winkler C., Modi W., Smith M.W., et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998, 279:389-393.
13. Benboubker L., Watier H., Carion A., et al. Association between the SDF1-3'A allele and high levels of CD34(+) progenitor cells mobilized into peripheral blood in humans. Br J Haematol 2001, 113:247-250.
14. Martin-Antonio B., Carmona M., Falantes J., et al. Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors. Haematologica 2011, 96:102-109.
15. British Pharmacopoeia Commission Secretariat. The British Pharmacopoeia 2012 Appendix XIV N1. Numeration of CD34/CD45+ cells in haematopoietic products. Retrieved from 2012. http://bp2012.infostar.com.cn/Bp2012.aspx?tab=browse%26a=display%26n=13%26id=884.
16. Yang S.M., Chen H., Chen Y.H., et al. The more, the less: age and chemotherapy load are predictive of poor stem cell mobilization in patients with hematologic malignancies. Chinese Med J 2012, 125:593-598.
17. Bogunia-Kubik K., Gieryng A., Dlubek D., Lange A. The CXCL12-3'A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation. Bone Marrow Transplant 2009, 44:273-278.
18. Magierowska M., Lepage V., Boubnova L., et al. Distribution of the CCR5 gene 32 base pair deletion and SDF1-3'A variant in healthy individuals from different populations. Immunogenetics 1998, 48:417-419.